Uni Health (02211.HK) announced the complete sale of capsule production business to an independent third party - 43.78% equity of Jilin Jintiandi Uni Health Group, for a cash consideration of RMB 43 million. The net proceeds will be used for general operating funds.
大健康國際(02211.HK)作價4,300萬人民幣出售膠囊生產業務
Uni Health (02211.HK) sells capsule production business at a price of 43 million RMB.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated